Type-A botulinum toxin (BTX-A) is today frequently used for cosmeceutical purposes. In addition, it is used extensively in the treatment of the patients with spasmodic torticollis in neurosurgery practice. However, patients admitted to the emergency department with adverse reactions / adverse events observed, especially after these applications constitute a severe problem. In this study, it was aimed to systematically evaluate the adverse reactions or events reported in the literature after administering BTX-A injections to the patients with spasmodic torticollis between Nov-1-1997 and Feb-13-2018. The data obtained from this research, it will be able to be seen a bigger image about these negativities that may arise. Thus, the management strategies for the treatment of such cases admitted to emergency departments can be planned more easily.
 

Download Full Text - PDF